...
首页> 外文期刊>Hospital pharmacy. >Are Health Care Professionals Paying Attention to the Food and Drug Administration's Safety Warnings?
【24h】

Are Health Care Professionals Paying Attention to the Food and Drug Administration's Safety Warnings?

机译:卫生保健专业人员是否要注意食品药品管理局的安全警告?

获取原文
获取原文并翻译 | 示例

摘要

The mission of the Food and Drug Administration's (FDA) Center for Drug Evaluation and Research is to promote and protect public health by assuring that safe and effective drugs are available to Americans. Within this role, the FDA must provide practitioners with up-to-date information regarding the safety of medications approved by the agency. Some of this is achieved by announcements issued through the FDA's MedWATCH: The FDA Safety Information and Adverse Event Reporting Program, by changes in the drug labeling that can be found on the FDA "Web site (http://www.fda.gov/medwatch/saf ety.htm), as well as changes made in the manufacturer's package inserts and labeling.
机译:美国食品药品监督管理局(FDA)药物评估和研究中心的任务是,通过确保美国人可以使用安全有效的药物来促进和保护公共健康。在这一职责范围内,FDA必须为从业人员提供有关该机构批准的药物安全性的最新信息。通过FDA的MedWATCH:FDA安全信息和不良事件报告计划发布的公告,以及通过FDA“网站(http://www.fda.gov/ medwatch / saf ety.htm),以及制造商包装说明书和标签上的更改。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号